CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05684432
NCT05684432N/ACompleted

Frequency and Classification of Radiation-induced Diarrhoea in Patients With Prostate and Rectal Cancer During Curative External Radiotherapy

Aalborg University Hospital·observational·Posted Jan 13, 2023·Updated Jan 24, 2025

In Brief

An observational study evaluating No intervention for Radiation-induced Diarrhoea in Prostate and Rectal Cancer. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Approx. 80% of patients with prostate and rectal cancer who receive radiation therapy (RT) experience acute radiation-induced diarrhea (RID). RID has major impact on patients' quality of life, can lead to pause or early termination of RT and chronic diarrhea. RID is poorly described with few details of type and severity of RID in clinical practice and in the literature. We are conducting an observational study in patients in patients who receive curative EBRT radiation for prostate and rectal cancer to uncover the frequency and classifications of RID.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 13, 2023
Enrollment StartJun 1, 2022
Primary CompletionJul 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 3.5 years ago

Interventions

No interventionother

No intervention